Insider · CIK 0001529611
Carole Ben-Maimon
Files at LRMR (Larimar Therapeutics, Inc.). First filing -, latest -.
In brief
Carole Ben-Maimon files SEC Form 4 as CEO, president and director at LRMR (Larimar Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Carole Ben-Maimon has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | LRMR Larimar Therapeutics, Inc. | AGrant or award Common Stock | +100,100 | $0.00 | $0 | 368,276 | Jan 27, 2026 |
| Jan 26, 2026 | LRMR Larimar Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +600,600 | $0.00 | $0 | 600,600 | Jan 27, 2026 |
| Jan 22, 2025 | LRMR Larimar Therapeutics, Inc. | AGrant or award Common Stock | +91,000 | $0.00 | $0 | 387,208 | Jan 24, 2025 |
| Jan 22, 2025 | LRMR Larimar Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +546,000 | $0.00 | $0 | 546,000 | Jan 24, 2025 |
Questions about Carole Ben-Maimon
Answered from the filings on this page, as of the latest one.
Is Carole Ben-Maimon buying or selling?
Carole Ben-Maimon has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Carole Ben-Maimon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carole Ben-Maimon has 0.
Where does Carole Ben-Maimon file Form 4?
Carole Ben-Maimon has filed Form 4 at LRMR (Larimar Therapeutics, Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.